European Commission Directorate-General for International Partnerships (EuropeAid HQ)

Saving patients from severe heart failure: FLOWMAKER

Last update: Mar 28, 2023 Last update: Mar 28, 2023

Details

Locations:France
Start Date:Oct 1, 2022
End Date:Sep 30, 2024
Contract value:EUR 18,885,643
Sectors:Health, Science & InnovationHealth, Science & Innovation
Categories:Grants
Date posted:Mar 28, 2023

Associated funding

Associated experts

Description

Programme(s): HORIZON.3.1 - The European Innovation Council (EIC)

Topic(s): HORIZON-EIC-2022-ACCELERATOROPEN-01 - EIC Accelerator Open

Call for proposal: HORIZON-EIC-2022-ACCELERATOR-01

Funding Scheme: EIC-ACC - EIC-ACC

Grant agreement ID: 190146685

Objective:
The ICOMS FlowMaker® is the first intracardiac assist device that overcomes all shortcomings of current and under development devices and restores patient's quality of life. Its design perfectly fits all the needs of patients suffering from severe heart failure. Implanted inside the left ventricle and synchronized with natural heartbeat, it assists the heart to push blood in a physiological way. The very low electrical consumption allows for wireless functioning. With no driveline crossing the skin, the risk of infection is suppressed. Without bypass to aorta and thanks to its pulsatile mode, the risk of bleeding is very low. The ICOMS FlowMaker® addresses the market of severe heart failure, where 95% of patients are left without any solution. The aim of the project is to conduct the clinical trials to enter the EU market in 2026, then the US market, allowing to finally achieve EU sovereignty in severe heart failure treatment.

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.